Apotex Urges High Court To Nix 'Lead Compound' Patent Test
Apotex Inc. asked the U.S. Supreme Court on Monday to review the Federal Circuit's so-called lead compound test for evaluating the obviousness of pharmaceutical patents, arguing the test makes it too...To view the full article, register now.
Already a subscriber? Click here to view full article